Marco Piccinini, Asaho Takei
Fluidigm has appointed Marco Piccinini as commercial lead for Europe and Asaho Takei as general manager in Japan, Fluidigm President and CEO Chris Linthwaite announced during the company's Q1 earnings call this week. Piccinini has held senior commercial leadership positions at PerkinElmer, Applied Biosystems, Life Technologies, and Thermo Fisher Scientific. Takei previously worked for Illumina for more than 15 years.
José Baselga, Brook Byers, Kaye Foster
Grail has appointed José Baselga, Brook Byers, and Kaye Foster to its board of directors. They will join currently serving board members Bill Rastetter, Jeff Huber, Richard Klausner, and Robert Nelsen. Baselga is the physician-in-chief and chief medical officer at Memorial Sloan Kettering Cancer Center, and professor of medicine at Weill Cornell Medical College. He also serves as the chairman of Grail's Scientific Advisory Board. Byers is a senior partner and founding member of Kleiner Perkins Caufield & Byers (KPCB). Foster currently advises CEOs and leadership teams focusing on business transformations, talent management strategy, and human resources strategy development and implementation. She most recently served as senior VP of Global Human Resources for Onyx Pharmaceuticals.
Travis Lacey, Dale Gordon, Gary Altman, Steven Ness
Human Longevity has hired several new senior staff. Travis Lacey was named chief corporate development officer; Dale Gordon was named chief commercial officer; Gary Altman was named chief operating officer; and Steven Ness was named chief services lead. Lacey comes from GE Healthcare where he was the managing director, leading the divestiture practice and portfolio optimization. Before that he was with investment banks Jefferies and R.W. Baird. Gordon was most recently GM of account management at GE Healthcare. Prior to that, he was with EMD Millipore, now Millipore Sigma and part of Merck KGaA. Altman has more than 25 years of experience leading startups and has served as CEO, COO, VP, and GM at various firms. Ness most recently was director of client services at GE Healthcare's Clarient Diagnostics business. Previously, he held medical affairs and marketing positions at Quidel.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.